Click here to access full coverage of CMS in The Lawyer UK 200 2013. Featuring the UK’s leading law firms ranked by turnover, as well as extensive benchmarking data, the report is a comprehensive market intelligence resource for the UK legal sector.
No. of Lawyers: 36
Pharmaceuticals and the general life sciences sector were behind CMS’ move into Beijing in September 2012, adding to its existing presence in Shanghai. The firm cited expansion plans in China by the pharmaceutical multinationals as a “huge market opportunity”, with the country on the verge of becoming “one of the world's biggest pharmaceutical powerhouses”.
Nick Beckett, the firm's life sciences group head was appointed to lead the firm's push into the Chinese capital. He said at the time of the launch that: “China is an especially attractive mergers and acquisitions destination for European and US drug-makers hoping to ride out the wave of imminent patent expirations. It is a prime location for companies looking to diversify their pipelines and make up for any shortfall.”
The Asia Pacific profile is an edited version of a full write-up that appears in The Lawyer Asia Pacific 150, a comprehensive analysis of the legal market in the region that ranks the top 100 local firms and leading 50 international players by headcount. For more information and to purchase your copy please click here.
News from The Lawyer
Briefings from CMS
The energy department at CMS Cameron McKenna covers oil and gas, electricity, renewables, power and energy-related disputes.
Analysis from The Lawyer
Shell legal director Peter Rees is switching litigation control away from external counsel to a unified global team of in-housers
Our list of the summer’s big deals shows how London law firms kept busy with work from Asia as well as more familiar sources
Browse This Firm’s
160 Aldersgate Street
Turnover (£m): 679.30
No. of Lawyers: 2,335
No. of Lawyers (Asia Pacific): 36
Offices (Asia Pacific): 2